RPG Life Sciences
Rpg Life Sciences Performance
Day Range
- Low 1,362.00
- High 1,388.75
52 Week Range
- Low 645.50
- High 1,505.00
- Open Price1,388.75
- Previous Close1,379.75
- Volume6126
Start SIP in RPG Life Sciences
Start SIPRpg Life Sciences Investment Rating
-
Master Rating:
-
R P G Life Sciences has an operating revenue of Rs. 550.45 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 18% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 32% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 154 | 148 | 118 | 131 | 135 | 129 | 104 |
Operating Expenses Qtr Cr | 116 | 116 | 103 | 101 | 105 | 101 | 90 |
Operating Profit Qtr Cr | 37 | 32 | 16 | 29 | 30 | 28 | 14 |
Depreciation Qtr Cr | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 9 | 8 | 3 | 7 | 7 | 7 | 3 |
Net Profit Qtr Cr | 26 | 22 | 10 | 19 | 20 | 18 | 8 |
Rpg Life Sciences Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹1,396.37
- 50 Day
- ₹1,368.75
- 100 Day
- ₹1,274.18
- 200 Day
- ₹1,126.05
- 20 Day
- ₹1,412.02
- 50 Day
- ₹1,384.72
- 100 Day
- ₹1,278.29
- 200 Day
- ₹1,047.04
Rpg Life Sciences Resistance and Support
Resistance | |
---|---|
First Resistance | 1,382.47 |
Second Resistance | 1,398.98 |
Third Resistance | 1,409.22 |
RSI | 43.94 |
MFI | 32.56 |
MACD Single Line | -0.14 |
MACD | -8.81 |
Support | |
---|---|
First Resistance | 1,355.72 |
Second Resistance | 1,345.48 |
Third Resistance | 1,328.97 |
Rpg Life Sciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 7,286 | 441,532 | 60.6 |
Week | 17,046 | 913,815 | 53.61 |
1 Month | 21,705 | 1,004,069 | 46.26 |
6 Month | 48,330 | 2,078,173 | 43 |
Rpg Life Sciences Result Highlights
RPG Life Sciences Synopsis
NSE-Medical-Diversified
Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 512.81 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2023. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.Market Cap | 2,261 |
Sales | 550 |
Shares in Float | 0.45 |
No of funds | 32 |
Yield | 0.87 |
Book Value | 7.42 |
U/D Vol ratio | 1.7 |
LTDebt / Equity | |
Alpha | 0.17 |
Beta | 0.8 |
RPG Life Sciences
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 72.81% | 72.81% | 72.81% | 72.61% |
Mutual Funds | 0.82% | |||
Insurance Companies | 0.51% | |||
Foreign Portfolio Investors | 0.46% | 0.33% | 0.38% | 0.25% |
Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
Individual Investors | 18.41% | 19.45% | 19.91% | 20.26% |
Others | 6.98% | 7.4% | 6.9% | 6.87% |
RPG Life Sciences Management
Name | Designation |
---|---|
Mr. Harsh V Goenka | Chairman |
Mr. Yugal Sikri | Managing Director |
Mr. Rajat Bhargava | Non Executive Director |
Mr. Sachin Nandgaonkar | Non Executive Director |
Mr. Manoj K Maheshwari | Independent Director |
Mr. Narendra Ambwani | Independent Director |
Ms. Zahabiya Khorakiwala | Independent Director |
Mr. Bhaskar Iyer | Independent Director |
Dr. Lalit S Kanodia | Independent Director |
Mr. Mahesh S Gupta | Independent Director |
Rpg Life Sciences Forecast
Price Estimates
Rpg Life Sciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-10-18 | Quarterly Results | |
2023-07-28 | Quarterly Results | |
2023-04-28 | Audited Results & Final Dividend | |
2023-02-01 | Quarterly Results | |
2022-10-17 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-07-21 | FINAL | Rs.12.00 per share(150%)Final Dividend |
2022-07-15 | FINAL | Rs.9.60 per share(120%)Final Dividend |
2021-08-17 | FINAL | Rs.7.20 per share(90%)Dividend |
RPG Life Sciences FAQs
What is Share Price of RPG Life Sciences ?
RPG Life Sciences share price is ₹1,365 As on 12 December, 2023 | 00:59
What is the Market Cap of RPG Life Sciences ?
The Market Cap of RPG Life Sciences is ₹2259.1 Cr As on 12 December, 2023 | 00:59
What is the P/E ratio of RPG Life Sciences ?
The P/E ratio of RPG Life Sciences is 29.2 As on 12 December, 2023 | 00:59
What is the PB ratio of RPG Life Sciences ?
The PB ratio of RPG Life Sciences is 7.3 As on 12 December, 2023 | 00:59